Mechanism of action
The mechanism of action of the drug is based on competitive antagonism with para-aminobenzoic acid (PABA). PABA is an essential growth factor for Mycobacterium tuberculosis. By replacing it in biochemical reactions, sodium aminosalicylate blocks the pathogen's enzyme systems, which ultimately leads to the inhibition of folate synthesis.
Important condition: the drug acts selectively. It affects exclusively mycobacteria that are in the active multiplication phase. It has no effect on bacteria in the resting phase.
Pharmacological effects
The drug exerts a tuberculostatic effect — it does not kill bacteria directly, but halts their growth and reproduction. In the classification of antitubercular agents, it belongs to the group of synthetic drugs (derivatives of para-aminosalicylic acid).
Its antitubercular activity is rated as moderate: it is significantly lower than that of isoniazid or aminoglycoside antibiotics (e.g., streptomycin). For this reason, sodium aminosalicylate is never used as monotherapy. Its main pharmacological task in the treatment regimen is to enhance the effect of more potent antitubercular agents and, most importantly, to slow down the development of resistance in mycobacteria to the main therapy.
Pharmacokinetics
When administered orally (per os), the drug demonstrates good absorption. However, its use is associated with a pronounced irritant effect on the mucous membrane of the gastrointestinal tract.
The metabolism of sodium aminosalicylate occurs predominantly in the liver, as well as partially in the gastrointestinal tract itself. The elimination of metabolites and unchanged drug is carried out through the kidneys with urine.
Indications for use
The drug is indicated for all forms of tuberculosis.
The main rule of administration: it is used strictly as part of combination therapy (along with isoniazid, streptomycin, and other drugs).
Interesting fact: the para-aminosalicylic acid (PAS) residue is structurally part of the capreomycin molecule — a reserve natural peptide antibiotic used for resistant forms of tuberculosis.
Side effects
The spectrum of adverse reactions is largely due to the pharmacokinetic features of the drug:
- Gastrointestinal tract: due to the irritant effect on the mucosa, dyspeptic disorders (nausea, vomiting, diarrhea) develop most frequently.
- Immune system: various allergic reactions are possible.
Dosage forms and administration
According to the prescription reference guide, sodium aminosalicylate is available in the following dosage forms:
- Powder.
- 0.5 g tablets.
- 0.5 g enteric-coated tablets (this form is specially designed to minimize the irritant effect on the gastric mucosa, as the drug is released only in the intestine).
- Vials of 3% solution, 250 and 500 ml.
Methods of administration:
- Orally: prescribed at 3–4 g per single dose.
- Parenterally: administered intravenously as a drip of 250 ml of a 3% solution.
Briefly: answers to topical questions
To which group of antitubercular drugs (first-line or second-line) does sodium aminosalicylate belong?
Sodium aminosalicylate belongs to second-line antitubercular drugs, meaning it is a reserve agent. This group of medications is prescribed to patients in the event of the pathogen developing resistance to the main first-line drugs. In terms of origin classification, the drug belongs to synthetic agents, being a derivative of para-aminosalicylic acid (PAS).
PAS — Potent Antagonist of Synthesis (folate acid). It competes with PABA, leaving the mycobacterium without folates.
Class and exam questions
Why is sodium aminosalicylate not prescribed as monotherapy?
Its activity is lower than that of primary drugs (isoniazid, aminoglycosides). It is used only in combination to enhance the overall effect and prevent the development of mycobacterial resistance.
Which forms of mycobacteria does PAS affect?
The drug is effective only against mycobacteria in the active replication phase and has absolutely no effect on bacteria in the resting phase.
What is the main side effect when taking the drug orally?
Dyspeptic disorders (nausea, vomiting, diarrhea) occur most frequently. This is due to the pronounced irritating effect of the drug on the GI mucosa.
What else to study on this topic
- Synthetic antitubercular agents: complete classification
- Bacterial folate metabolism and drug targets
- Principles of combination therapy for tuberculosis
- Mechanisms of mycobacterial resistance development
- Comparison of PAS with isonicotinic acid hydrazide derivatives
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Sodium aminosalicylate" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.